Global Solid Tumor Therapeutics Market Analysis By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Tyrosine kinase inhibitors, Proteasome inhibitor, Hedgehog pathway inhibitor, Others), By Route of Administration (Oral, Parenteral, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others, Distribution Channel) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Feb 2024
- Report ID: 135794
- Number of Pages:
- Format:
-
-
-
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Sanofi Company Profile
- Pfizer Inc Company Profile
- GlaxoSmithKline plc
- Novartis AG Company Profile
- Merck & Co. Inc.
- Allergan
- AstraZeneca Plc Company Profile
- Johnson & Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Bristol-Myers Squibb Company
- Bayer AG Company Profile
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |